{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:06:55Z","timestamp":1763417215848,"version":"3.45.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05660-8","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T06:33:31Z","timestamp":1763361211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibody responses to polymorphic Plasmodium falciparum merozoite antigens in Malawian children with severe and uncomplicated malaria"],"prefix":"10.1186","volume":"24","author":[{"given":"Carlota","family":"Doba\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Rogerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrie E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana S.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"5660_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","volume":"22","author":"DL Doolan","year":"2009","unstructured":"Doolan DL, Doba\u00f1o C, Baird JK. Acquired immunity to malaria. Clin Microbiol Rev. 2009;22:13\u201336.","journal-title":"Clin Microbiol Rev"},{"key":"5660_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0169-4758(91)90096-7","volume":"7","author":"B Greenwood","year":"1991","unstructured":"Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria? Parasitol Today. 1991;7:277\u201381.","journal-title":"Parasitol Today"},{"key":"5660_CR3","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.4049\/jimmunol.168.7.3444","volume":"168","author":"MA Nielsen","year":"2002","unstructured":"Nielsen MA, Staalsoe T, Kurtzhals JAL, Goka BQ, Dodoo D, Alifrangis M, et al. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity. J Immunol. 2002;168:3444\u201350.","journal-title":"J Immunol"},{"key":"5660_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/432761","volume":"192","author":"PC Bull","year":"2005","unstructured":"Bull PC, Pain A, Ndungu FM, Kinyanjui SM, Roberts DJ, Newbold CI, et al. Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity. J Infect Dis. 2005;192:1119\u201326.","journal-title":"J Infect Dis"},{"key":"5660_CR5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1086\/527490","volume":"197","author":"C Doba\u00f1o","year":"2008","unstructured":"Doba\u00f1o C, Rogerson SJ, Mackinnon MJ, Cavanagh DR, Taylor TE, Molyneux ME, et al. Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria. J Infect Dis. 2008;197:766\u201374.","journal-title":"J Infect Dis"},{"key":"5660_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.vaccine.2011.11.069","volume":"30","author":"SD Lourembam","year":"2012","unstructured":"Lourembam SD, Baruah S. Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India. Vaccine. 2012;30:767\u201373.","journal-title":"Vaccine"},{"key":"5660_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/intimm\/4.9.1055","volume":"4","author":"EM Riley","year":"1992","unstructured":"Riley EM, Olerup O, Bennett S, Rowe P, Allen SJ, Blackman MJ, et al. MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. Int Immunol. 1992;4:1055\u201363.","journal-title":"Int Immunol"},{"key":"5660_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","volume":"192","author":"S Cohen","year":"1961","unstructured":"Cohen S, Mcgregor Ia, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961;192:733\u20137.","journal-title":"Nature"},{"key":"5660_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/263132a0","volume":"263","author":"RJM Wilson","year":"1976","unstructured":"Wilson RJM, Phillips RS. Method to test inhibitory antibodies in human sera to wild populations of Plasmodium falciparum. Nature. 1976;263:132\u20134.","journal-title":"Nature"},{"key":"5660_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/milmed\/131.suppl_9.961","volume":"131","author":"PCC Garnham","year":"1966","unstructured":"Garnham PCC. Comments on biology of human malaria. Mil Med. 1966;131:961\u20132.","journal-title":"Mil Med"},{"key":"5660_CR11","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.1016\/S0167-5699(05)80020-9","volume":"12","author":"KP Day","year":"1991","unstructured":"Day KP, Marsh K. Naturally acquired immunity to Plasmodium falciparum. Immunol Today. 1991;12:A68\u201371.","journal-title":"Immunol Today"},{"key":"5660_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/milmed\/134.9.1135","volume":"134","author":"FC Cadigan","year":"1969","unstructured":"Cadigan FC, Chaicumpa V. Plasmodium falciparum in the white-handed gibbon: protection afforded by previous infection with homologous and heterologous strains obtained in Thailand. Mil Med. 1969;134:1135\u20139.","journal-title":"Mil Med"},{"key":"5660_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/76272","volume":"6","author":"DJ Conway","year":"2000","unstructured":"Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N, et al. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med. 2000;6:689\u201392.","journal-title":"Nat Med"},{"key":"5660_CR14","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1128\/IAI.71.4.1833-1842.2003","volume":"71","author":"SD Polley","year":"2003","unstructured":"Polley SD, Tetteh KKA, Cavanagh DR, Pearce RJ, Lloyd JM, Bojang KA, et al. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria. Infect Immun. 2003;71:1833\u201342.","journal-title":"Infect Immun"},{"key":"5660_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-3024.2009.01178.x","volume":"32","author":"FHA Osier","year":"2010","unstructured":"Osier FHA, Murungi LM, Fegan G, Tuju J, Tetteh KK, Bull PC, et al. Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria. Parasite Immunol. 2010;32:193\u2013201.","journal-title":"Parasite Immunol"},{"key":"5660_CR16","first-page":"619","volume":"27","author":"M Ciuca","year":"1934","unstructured":"Ciuca M, Ballif L, Chelarescu-Vireu M. Transactions of the royal society of tropical medicine and hygiene. Immunity in malaria. 1934;27:619\u201322.","journal-title":"Immunity in malaria"},{"key":"5660_CR17","first-page":"873","volume":"35","author":"GM Jeffery","year":"1966","unstructured":"Jeffery GM. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull World Health Organ. 1966;35:873\u201382.","journal-title":"Bull World Health Organ"},{"key":"5660_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-3083.2000.00787.x","volume":"52","author":"B Bolad","year":"2000","unstructured":"Bolad B. Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization. Scand J Immunol. 2000;52:233\u20139.","journal-title":"Scand J Immunol"},{"key":"5660_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1128\/iai.60.4.1422-1433.1992","volume":"60","author":"GS Hui","year":"1992","unstructured":"Hui GS, Hashimoto A, Chang SP. Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum. Infect Immun. 1992;60:1422\u201333.","journal-title":"Infect Immun"},{"key":"5660_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00359","volume":"5","author":"AE Barry","year":"2014","unstructured":"Barry AE, Arnott A. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol. 2014;5:359.","journal-title":"Front Immunol"},{"key":"5660_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0166-6851(96)02826-5","volume":"85","author":"DR Cavanagh","year":"1997","unstructured":"Cavanagh DR, McBride JS. Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol Biochem Parasitol. 1997;85:197\u2013211.","journal-title":"Mol Biochem Parasitol"},{"key":"5660_CR22","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1128\/iai.63.11.4382-4388.1995","volume":"63","author":"RR Taylor","year":"1995","unstructured":"Taylor RR, Smith DB, Robinson VJ, McBride JS, Riley EM. Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect Immun. 1995;63:4382\u20138.","journal-title":"Infect Immun"},{"key":"5660_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4269\/ajtmh.1988.39.150","volume":"39","author":"C Chizzolini","year":"1988","unstructured":"Chizzolini C, Dupont A, Akue JP, Kaufmann MH, Verdini AS, Pessi A, et al. Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon. Am J Trop Med Hyg. 1988;39:150\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR24","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1128\/iai.64.7.2716-2723.1996","volume":"64","author":"YP Shi","year":"1996","unstructured":"Shi YP, Sayed U, Qari SH, Roberts JM, Udhayakumar V, Oloo AJ, et al. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun. 1996;64:2716\u201323.","journal-title":"Infect Immun"},{"key":"5660_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4269\/ajtmh.1996.54.443","volume":"54","author":"F Al-Yaman","year":"1996","unstructured":"Al-Yaman F, Genton B, Kramer KJ, Chang SP, Hui GS, Baisor M, et al. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am J Trop Med Hyg. 1996;54:443\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/infdis\/173.3.765","volume":"173","author":"AF Egan","year":"1996","unstructured":"Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow DC, et al. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kda c-terminal fragment of the merozoite surface antigen, PfMSP-l. J Infect Dis. 1996;173:765\u20138.","journal-title":"J Infect Dis"},{"key":"5660_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4269\/ajtmh.1998.58.211","volume":"58","author":"OH Branch","year":"1998","unstructured":"Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, et al. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg. 1998;58:211\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR28","first-page":"54","volume":"37","author":"F Al-Yaman","year":"1994","unstructured":"Al-Yaman F, Genton B, Mokela D, Alpers MP. Resistance of Plasmodium falciparum in vivo to 3 days\u2019 treatment with quinine and single-dose Fansidar. PNG Med J. 1994;37:54\u20136.","journal-title":"PNG Med J"},{"key":"5660_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-3024.1995.tb00920.x","volume":"17","author":"F Al-Yaman","year":"1995","unstructured":"Al-Yaman F, Genton B, Anders R, Taraika J, Ginny M, Mellor S, et al. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol. 1995;17:493\u2013501.","journal-title":"Parasite Immunol"},{"key":"5660_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/iai.61.1.40-47.1993","volume":"61","author":"R Tolle","year":"1993","unstructured":"Tolle R, Fr\u00fch K, Doumbo O, Koita O, N\u2019Diaye M, Fischer A, et al. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect Immun. 1993;61:40\u20137.","journal-title":"Infect Immun"},{"key":"5660_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1558-5646.1998.tb01656.x","volume":"52","author":"LH Taylor","year":"1998","unstructured":"Taylor LH, Mackinnon MJ, Read AF. Virulence of mixed-clone and single-clone infections of the rodent malaria Plasmodium chabaudi. Evolution. 1998;52:583\u201391.","journal-title":"Evolution"},{"key":"5660_CR32","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1128\/iai.59.10.3498-3503.1991","volume":"59","author":"HM Etlinger","year":"1991","unstructured":"Etlinger HM, Caspers P, Matile H, Schoenfeld HJ, Stueber D, Takacs B. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun. 1991;59:3498\u2013503.","journal-title":"Infect Immun"},{"key":"5660_CR33","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1128\/iai.59.7.2403-2411.1991","volume":"59","author":"D Pye","year":"1991","unstructured":"Pye D, Edwards SJ, Anders RF, O\u2019Brien CM, Franchina P, Corcoran LN, et al. Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria. Infect Immun. 1991;59:2403\u201311.","journal-title":"Infect Immun"},{"key":"5660_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004708","volume":"4","author":"BR Ogutu","year":"2009","unstructured":"Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, et al. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS ONE. 2009;4:e4708.","journal-title":"PLoS ONE"},{"key":"5660_CR35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1086\/339342","volume":"185","author":"B Genton","year":"2002","unstructured":"Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1\u20132b trial in Papua New Guinea. J Infect Dis. 2002;185:820\u20137.","journal-title":"J Infect Dis"},{"key":"5660_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1473-3099(24)00752-7","volume":"25","author":"HM Natama","year":"2025","unstructured":"Natama HM, Salkeld J, Som\u00e9 A, Soremekun S, Diallo S, Traor\u00e9 O, et al. Safety and efficacy of the blood-stage malaria vaccine RH5.1\/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children. Lancet Infect Dis. 2025;25:495\u2013506.","journal-title":"Lancet Infect Dis"},{"key":"5660_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4269\/ajtmh.1996.54.18","volume":"54","author":"P Daubersies","year":"1996","unstructured":"Daubersies P, Sallenave-Sales S, Magne S, Trape JF, Contamin H, Fandeur T, et al. Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg. 1996;54:18\u201326.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR38","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4269\/ajtmh.1996.54.632","volume":"54","author":"H Contamin","year":"1996","unstructured":"Contamin H, Fandeur T, Rogier C, Bonnefoy S, Konate L, Trape JF, et al. Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. Am J Trop Med Hyg. 1996;54:632\u201343.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4269\/ajtmh.1997.56.538","volume":"56","author":"A F\u00e4rnert","year":"1997","unstructured":"F\u00e4rnert A, Snounou G, Rooth I, Bjorkman A. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg. 1997;56:538\u201347.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"5660_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4269\/ajtmh.1984.33.1","volume":"33","author":"S Tharavanij","year":"1984","unstructured":"Tharavanij S, Warrell MJ, Tantivanich S, Tapchaisri P, Chongsa-Nguan M, Prasertsiriroj V, et al. Factors contributing to the development of cerebral malaria. I. Humoral immune responses. Am J Trop Med Hyg. 1984;33(1):1\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2249.1992.tb06948.x","volume":"89","author":"OA Erunkulu","year":"1992","unstructured":"Erunkulu OA, Hill AV, Kwiatkowski DP, Todd JE, Iqbal J, Berzins K, et al. Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol. 1992;89:296\u2013300.","journal-title":"Clin Exp Immunol"},{"key":"5660_CR42","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1128\/CVI.00156-13","volume":"20","author":"H Ahmed Ismail","year":"2013","unstructured":"Ahmed Ismail H, Ribacke U, Reiling L, Normark J, Egwang T, Kironde F, et al. Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria. Clin Vaccine Immunol. 2013;20:1170\u201380.","journal-title":"Clin Vaccine Immunol"},{"key":"5660_CR43","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.4269\/ajtmh.2007.76.1084","volume":"76","author":"KKG Scopel","year":"2007","unstructured":"Scopel KKG, da Silva-Nunes M, Malafronte RS, Braga EM, Ferreira MU. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians. Am J Trop Med Hyg. 2007;76:1084\u201391.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR44","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4269\/ajtmh.1997.56.430","volume":"56","author":"F Al-Yaman","year":"1997","unstructured":"Al-Yaman F, Genton B, Reeder JC, Mokela D, Anders RF, Alpers MP. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. Am J Trop Med Hyg. 1997;56:430\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"5660_CR45","first-page":"441","volume":"71","author":"ME Molyneux","year":"1989","unstructured":"Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989;71:441\u201359.","journal-title":"Q J Med"},{"key":"5660_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-024-05235-z","volume":"24","author":"C Doba\u00f1o","year":"2025","unstructured":"Doba\u00f1o C, Rogerson SJ, Taylor TE, McBride JS. Genotypic and antigenic diversity of Plasmodium falciparum merozoite proteins in Malawian children with severe and uncomplicated malaria. Malar J. 2025;24(1).","journal-title":"Malar J"},{"key":"5660_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0166-6851(94)90144-9","volume":"64","author":"PA Burghaus","year":"1994","unstructured":"Burghaus PA, Holder AA. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol. 1994;64:165\u20139.","journal-title":"Mol Biochem Parasitol"},{"key":"5660_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4049\/jimmunol.161.1.347","volume":"161","author":"DR Cavanagh","year":"1998","unstructured":"Cavanagh DR, Elhassan IM, Roper C, Robinson VJ, Giha H, Holder AA, et al. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol. 1998;161:347\u201359.","journal-title":"J Immunol"},{"key":"5660_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1006\/expr.1994.1070","volume":"79","author":"I Felger","year":"1994","unstructured":"Felger I, Tavul L, Kabintik S, Marshall V, Genton B, Alpers M, et al. Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. Exp Parasitol. 1994;79:106\u201316.","journal-title":"Exp Parasitol"},{"key":"5660_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1006\/expr.1995.1096","volume":"81","author":"F Engelbrecht","year":"1995","unstructured":"Engelbrecht F, Felger I, Genton B, Alpers M, Beck FP. Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes. Exp Parasitol. 1995;81:90\u20136.","journal-title":"Exp Parasitol"},{"key":"5660_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/PL00006215","volume":"45","author":"I Felger","year":"1997","unstructured":"Felger I, Marshal VM, Reeder JC, Hunt JA, Mgone CS, Beck HP. Sequence diversity and molecular evolution of the merozoite surface antigen 2 of Plasmodium falciparum. J Mol Evol. 1997;45:154\u201360.","journal-title":"J Mol Evol"},{"key":"5660_CR52","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1128\/IAI.01034-10","volume":"79","author":"J Stubbs","year":"2011","unstructured":"Stubbs J, Olugbile S, Saidou B, Simpore J, Corradin G, Lanzavecchia A. Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies. Infect Immun. 2011;79:1143\u201352.","journal-title":"Infect Immun"},{"key":"5660_CR53","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1128\/iai.59.4.1319-1324.1991","volume":"59","author":"K Fruh","year":"1991","unstructured":"Fruh K, Doumbo O, Muller HM, Koita O, McBride J, Crisanti A, et al. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect Immun. 1991;59:1319\u201324.","journal-title":"Infect Immun"},{"key":"5660_CR54","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1128\/IAI.00576-10","volume":"78","author":"FHA Osier","year":"2010","unstructured":"Osier FHA, Weedall GD, Verra F, Murungi L, Tetteh KKA, Bull P, et al. Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. Infect Immun. 2010;78:4625\u201333.","journal-title":"Infect Immun"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05660-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05660-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05660-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:02:26Z","timestamp":1763416946000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05660-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5660"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05660-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}